Carcinoma of the prostate. Guidelines for treatment: the role of antiandrogens
| Autor: | G. Daricello, Michele Pavone-Macaluso, Carlo Pavone, Vincenzo Serretta, Cacciatore M |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Oncology
Male medicine.medical_specialty Antiandrogens medicine.medical_treatment Urology Imidazolidines General Biochemistry Genetics and Molecular Biology Flutamide Prostate cancer chemistry.chemical_compound History and Philosophy of Science Prostate Internal medicine medicine Carcinoma Humans Libido business.industry General Neuroscience Imidazoles Prostatic Neoplasms Androgen Antagonists medicine.disease medicine.anatomical_structure chemistry Elevated transaminases Hormone therapy business |
| Zdroj: | Annals of the New York Academy of Sciences. 595 |
| ISSN: | 0077-8923 |
| Popis: | Our preliminary experience shows that flutamide is effective in patients with stage C or D prostate cancer. Local and distant response rates are comparable to those obtained with "classic" hormone therapy. Libido and sexual potency generally are unaffected. Palliation of symptoms, which is frequent, is usually accompanied by improved performance status and quality of life. Side effects are slight or moderate, but elevated transaminase levels in patients with borderline liver insufficiency are possible. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text